Back
Acumen Pharmaceuticals Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
18
ABOS
Acumen Pharmaceuticals
Last Price:
2.37
Seasonality Move:
-1.86%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABOS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Acumen Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.4 | Sell |
| 20-day SMA: | 2.77 | Sell |
| 50-day SMA: | 2.6 | Sell |
| 200-day SMA: | 3.06 | Sell |
| 8-day EMA: | 2.46 | Sell |
| 20-day EMA: | 2.61 | Sell |
| 50-day EMA: | 2.65 | Sell |
| 200-day EMA: | 3.03 | Sell |
Acumen Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 41.09 | Sell |
| Chaikin Money Flow: | 151645 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.47 - 3.07) | Sell |
| Bollinger Bands (100): | (2.36 - 3.02) | Sell |
Acumen Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Acumen Pharmaceuticals Stock
Is Acumen Pharmaceuticals Stock a Buy?
- Acumen Pharmaceuticals share price is 2.37 while ABOS 8-day simple moving average is 2.40, which is a Sell signal.
- The stock price of ABOS is 2.37 while Acumen Pharmaceuticals 20-day SMA is 2.77, which makes it a Sell.
- Acumen Pharmaceuticals 50-day simple moving average is 2.60 while ABOS share price is 2.37, making it a Sell technically.
- ABOS stock price is 2.37 and Acumen Pharmaceuticals 200-day simple moving average is 3.06, creating a Sell signal.
ABOS Technical Analysis vs Fundamental Analysis
Sell
18
Acumen Pharmaceuticals (ABOS)
is a Sell
Is Acumen Pharmaceuticals a Buy or a Sell?
-
Acumen Pharmaceuticals stock is rated a Sell
The current Acumen Pharmaceuticals [ABOS] share price is $2.37. The Score for ABOS is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Acumen Pharmaceuticals Stock Info
Market Cap:
142.39M
Price in USD:
2.37
Share Volume:
181.97K
Acumen Pharmaceuticals 52-Week Range
52-Week High:
5.09
52-Week Low:
2.08
Sell
18
Acumen Pharmaceuticals (ABOS)
is a Sell
Acumen Pharmaceuticals Share Price Forecast
-
What is the Acumen Pharmaceuticals stock price today?
The Acumen Pharmaceuticals stock price is 2.37 USD today. -
Will ABOS stock go up or go down?
Acumen Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Acumen Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Acumen Pharmaceuticals is overvalued.
Is Acumen Pharmaceuticals Stock a Buy?
- Acumen Pharmaceuticals share price is 2.37 while ABOS 8-day exponential moving average is 2.46, which is a Sell signal.
- The stock price of ABOS is 2.37 while Acumen Pharmaceuticals 20-day EMA is 2.61, which makes it a Sell.
- Acumen Pharmaceuticals 50-day exponential moving average is 2.65 while ABOS share price is 2.37, making it a Sell technically.
- ABOS stock price is 2.37 and Acumen Pharmaceuticals 200-day simple moving average is 3.03, creating a Sell signal.
Fundamental Analysis of Acumen Pharmaceuticals
Is Acumen Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.51 per share, and a decrease next year of $0.04 per share.
Technical Analysis of Acumen Pharmaceuticals
Should I short Acumen Pharmaceuticals stock?
- ABOS Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Acumen Pharmaceuticals is a Sell
- Acumen Pharmaceuticals Relative Strength Index (RSI) is 41.09, which suggest Acumen Pharmaceuticals is oversold
- The Bollinger Bands (25) for Acumen Pharmaceuticals is (2.47 - 3.07), which suggest Acumen Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Acumen Pharmaceuticals is (2.36 - 3.02), which suggest Acumen Pharmaceuticals is a Sell
* Acumen Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.